17700361

Source:http://linkedlifedata.com/resource/pubmed/id/17700361

Download in:

Switch to

Custom View

Named Graph Language Inference

Statements in which the resource exists as a subject.
Predicate	Object
rdf:type	pubmed:Citation
lifeskim:mentions	umls-concept:C0017431, umls-concept:C0076891, umls-concept:C0871261, umls-concept:C1274040, umls-concept:C1416603, umls-concept:C1512888, umls-concept:C1527129, umls-concept:C1704632, umls-concept:C1706817, umls-concept:C2603343, umls-concept:C2911692
pubmed:issue	9
pubmed:dateCreated	2007-8-16
pubmed:abstractText	We sought to determine whether polymorphisms in the large-conductance calcium and voltage-dependent potassium (BK) channel beta1 subunit gene, KCNMB1, are associated with blood pressure response to verapamil SR or adverse outcomes in the GENEtic substudy of the INternational VErapamil SR/trandolapril STudy (INVEST-GENES).
pubmed:grant	http://linkedlifedata.com/resource/pubmed/grant/HL 69758, http://linkedlifedata.com/resource/pubmed/grant/HL 74730, http://linkedlifedata.com/resource/pubmed/grant/K24 HL068834-05, http://linkedlifedata.com/resource/pubmed/grant/R01 HL074730-04, http://linkedlifedata.com/resource/pubmed/grant/RR017568
pubmed:commentsCorrections	http://linkedlifedata.com/resource/pubmed/commentcorrection/17700361-11057658, http://linkedlifedata.com/resource/pubmed/commentcorrection/17700361-11090555, http://linkedlifedata.com/resource/pubmed/commentcorrection/17700361-11156625, http://linkedlifedata.com/resource/pubmed/commentcorrection/17700361-11185670, http://linkedlifedata.com/resource/pubmed/commentcorrection/17700361-12011654, http://linkedlifedata.com/resource/pubmed/commentcorrection/17700361-12173798, http://linkedlifedata.com/resource/pubmed/commentcorrection/17700361-12411608, http://linkedlifedata.com/resource/pubmed/commentcorrection/17700361-12728311, http://linkedlifedata.com/resource/pubmed/commentcorrection/17700361-14657064, http://linkedlifedata.com/resource/pubmed/commentcorrection/17700361-15057310, http://linkedlifedata.com/resource/pubmed/commentcorrection/17700361-15282265, http://linkedlifedata.com/resource/pubmed/commentcorrection/17700361-15358732, http://linkedlifedata.com/resource/pubmed/commentcorrection/17700361-15781120, http://linkedlifedata.com/resource/pubmed/commentcorrection/17700361-16004724, http://linkedlifedata.com/resource/pubmed/commentcorrection/17700361-16046395, http://linkedlifedata.com/resource/pubmed/commentcorrection/17700361-16293791, http://linkedlifedata.com/resource/pubmed/commentcorrection/17700361-16458134, http://linkedlifedata.com/resource/pubmed/commentcorrection/17700361-9385294, http://linkedlifedata.com/resource/pubmed/commentcorrection/17700361-9809930
pubmed:language	eng
pubmed:journal	http://linkedlifedata.com/resource/pubmed/journal/101231005
pubmed:citationSubset	IM
pubmed:chemical	http://linkedlifedata.com/resource/pubmed/chemical/Antihypertensive Agents, http://linkedlifedata.com/resource/pubmed/chemical/Calcium Channel Blockers, http://linkedlifedata.com/resource/pubmed/chemical/DNA Primers, http://linkedlifedata.com/resource/pubmed/chemical/Indoles, http://linkedlifedata.com/resource/pubmed/chemical/Large-Conductance..., http://linkedlifedata.com/resource/pubmed/chemical/Verapamil, http://linkedlifedata.com/resource/pubmed/chemical/trandolapril
pubmed:status	MEDLINE
pubmed:month	Sep
pubmed:issn	1744-6872
pubmed:author	pubmed-author:BeitelsheesAmber LAL, pubmed-author:Cooper-DehoffRhonda MRM, pubmed-author:GongYanY, pubmed-author:INVEST Investigators, pubmed-author:JohnsonJulie AJA, pubmed-author:KnotHarm JHJ, pubmed-author:LangaeeTaimour YTY, pubmed-author:PepineCarl JCJ, pubmed-author:SadeeWolfgangW, pubmed-author:SchorkNicholas JNJ, pubmed-author:ShriverMark DMD, pubmed-author:WangDanxinD
pubmed:issnType	Print
pubmed:volume	17
pubmed:owner	NLM
pubmed:authorsComplete	Y
pubmed:pagination	719-29
pubmed:dateRevised	2009-11-18
pubmed:meshHeading	pubmed-meshheading:17700361-Aged, pubmed-meshheading:17700361-Antihypertensive Agents, pubmed-meshheading:17700361-Base Sequence, pubmed-meshheading:17700361-Calcium Channel Blockers, pubmed-meshheading:17700361-DNA Primers, pubmed-meshheading:17700361-Female, pubmed-meshheading:17700361-Genotype, pubmed-meshheading:17700361-Humans, pubmed-meshheading:17700361-Hypertension, pubmed-meshheading:17700361-Indoles, pubmed-meshheading:17700361-Large-Conductance Calcium-Activated Potassium Channel..., pubmed-meshheading:17700361-Male, pubmed-meshheading:17700361-Middle Aged, pubmed-meshheading:17700361-Pharmacogenetics, pubmed-meshheading:17700361-Polymorphism, Single Nucleotide, pubmed-meshheading:17700361-Verapamil
pubmed:year	2007
pubmed:articleTitle	KCNMB1 genotype influences response to verapamil SR and adverse outcomes in the INternational VErapamil SR/Trandolapril STudy (INVEST).
pubmed:affiliation	Department of Pharmacy Practice, University of Florida, College of Pharmacy, Gainesville, USA.
pubmed:publicationType	Journal Article, Clinical Trial, Research Support, Non-U.S. Gov't, Multicenter Study, Research Support, N.I.H., Extramural